Table 1.

Technical validation cohort of healthy donors

Median age (range) in years	33 (21; 64)
Gender, N (%)
Male	11 (24.4%)
Female	34 (75.6%)
CMV serostatus, N (%)
Positive	32 (71.1%)
Negative	13 (28.9%)